Table 2

Changes in non-specific airway responsiveness and sputum cells during inhalation challenges with cleaning agents

 Positive SICNegative SIC
BaselinePostchallengep ValueBaselinePostchallengep Value
AHR to histamine(n=17)(n=12)(n=27)(n=25)
 PC20, mg/mL1.4 (0.2–4.22)0.5 (0.4–3.0)*0.01913.0 (1.4–32.0)16.9 (2.6–32.0)0.267
 PC20 >16 mg/mL†2 (12)013 (48)13 (52)
 >Threefold decrease in PC205 (42)0
Sputum cell counts‡(n=13)(n=13)(n=7)(n=7)
 Total cell count, 106/mL0.54 (0.34–0.97)1.15 (0.53–2.17)0.0410.34 (0.26–1.89)0.65 (0.38–1.81)0.735
 Eosinophils, 106 cells/mL0.02 (0.01–0.04)0.12 (0.02–0.39)0.0060 (0–0.01)0 (0–0.01)0.345
 Eosinophils, %1.8 (0.8–7.2)10.0 (4.1–15.9)0.0090.2 (0–2.5)0.8 (0.2–1.5)0.786
 Increase in eosinophils >2%†8 (62)0
 Neutrophils, 106 cells/mL0.40 (0.17–0.70)0.71 (0.38–1.62)0.0090.19 (0.16–1.70)0.34 (0.25–1.52)0.866
 Neutrophils,%57.3 (42.4–72.5)69.5 (56.9–83.0)0.15260.3 (55.7–83.0)70.3 (52.5–84.0)0.866
  • Data are presented as median value with 25–75th IQR in parentheses unless otherwise specified.

  • *Histamine PC20 was measured at 7 h after the end of exposure in six participants and 24 h postexposure in six participants with positive SIC.

  • †Data expressed as n (% of available data).

  • ‡Data available on participants who performed an SIC from 2006 onwards.

  • AHR, airway hyper-responsiveness; PC20, provocative concentration of histamine causing a 20% fall in FEV1; SIC, specific inhalation challenge.